{
    "name": "calcitonin salmon",
    "comment": "Rx",
    "other_names": [
        "Miacalcin"
    ],
    "classes": [
        "Calcium Metabolism Modifiers"
    ],
    "source": "https://reference.medscape.com/drug/miacalcin-calcitonin-salmon-342816",
    "pregnancy": {
        "common": [
            "Miacalcin nasal spray is not indicated for use in females of reproductive potential; there are no data with use of in pregnant women; in an animal reproduction study, subcutaneous administration of calcitonin-salmon to pregnant rabbits during organogenesis at 4- 18 times the recommended parenteral human dose caused a decrease in fetal birth weights; no adverse developmental outcome was observed in rat with subcutaneous administration of cal-citonin-salmon at 9 times recommended human parenteral dose based on body surface area"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Nasal spray is not indicated for use in females of reproductive potential; there is no information on presence in human milk, effects on breastfed child, or on milk production; shown to inhibit lactation in rats"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to calcitonin-salmon"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Serious hypersensitivity reactions, including fatal anaphylaxis, reported; consider skin testing prior to treatment",
                "Hypocalcemia must be corrected before initiating therapy; also correct and treat other disorders affecting mineral metabolism (such as vitamin D deficiency); in patients at risk for hypocalcemia, provisions for parenteral calcium administration should be available during first several administrations of calcitonin salmon and serum calcium and symptoms of hypocalcemia should be monitored",
                "Use of injection for treatment of Pagetâ€™s disease or postmenopausal osteoporosis recommended in conjunction with adequate intake of calcium and vitamin D",
                "Overall incidence of malignancies reported to be higher in clinical trials among calcitonin-salmon-treated patients; this suggests increased risk of malignancies in calcitonin-salmon-treated patients compared to placebo-treated patients; not possible to exclude increased risk when calcitonin-salmon administered long-term subcutaneously, intramuscularly, or intravenously; benefits for individual patients should be carefully considered against possible risks",
                "Circulating antibodies reported with treatment; consider possibility of antibody formation in any patient with an initial response to injection who later stops responding to treatment",
                "Coarse granular casts and casts containing renal tubular epithelial cells reported in young adult volunteers at bed rest given injectable calcitonin-salmon to study effect of immobilization on osteoporosis; no other evidence of renal abnormality reported; urine sediment normalized after therapy was stopped; consider performing periodic examinations of urine sediment "
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium chloride",
            "description": {
                "common": "calcitonin salmon increases levels of magnesium chloride by decreasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium citrate",
            "description": {
                "common": "calcitonin salmon increases levels of magnesium citrate by decreasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium hydroxide",
            "description": {
                "common": "calcitonin salmon increases levels of magnesium hydroxide by decreasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium oxide",
            "description": {
                "common": "calcitonin salmon increases levels of magnesium oxide by decreasing renal clearance. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "magnesium sulfate",
            "description": {
                "common": "calcitonin salmon increases levels of magnesium sulfate by decreasing renal clearance. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Rhinitis",
            "percent": "12"
        },
        {
            "name": "Arthralgia",
            "percent": "4"
        },
        {
            "name": "Back pain",
            "percent": "5"
        },
        {
            "name": "Expistaxis",
            "percent": "4"
        },
        {
            "name": "Injection site reactions",
            "percent": "10"
        },
        {
            "name": "Nausea",
            "percent": "10"
        },
        {
            "name": "Headache",
            "percent": "3"
        },
        {
            "name": "Flushing of face or hands",
            "percent": "2-5"
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Possible allergic reactions",
            "percent": null
        },
        {
            "name": "Appetite decreased",
            "percent": null
        },
        {
            "name": "Edema of feet",
            "percent": null
        },
        {
            "name": "Eye pain",
            "percent": null
        },
        {
            "name": "Feverish sensation",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Nocturia",
            "percent": null
        },
        {
            "name": "Possible local irritative effects in the respiratory tract",
            "percent": null
        },
        {
            "name": "Salty taste",
            "percent": null
        },
        {
            "name": "Tremors",
            "percent": null
        }
    ]
}